Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 164 clinical trials
The Real World Study of Neoadjuvant Immunotherapy in Early Stage NSCLC in China

Several published clinical trials have shown the superiority of immunotherapy in neoadjuvant setting. Here we conducted this real world study to see whether neoadjuvant immunotherapy would bring MPR and survival benefits in NSCLC, for example, single agent immunotherapy or immunotherapy combination with chemotherapy. Furthermore biomarker analysis would be also performed …

alk gene translocation
lung cancer
non-small cell lung cancer
cancer
measurable disease
  • 0 views
  • 19 Feb, 2024
  • 1 location
Classification of Benign and Malignant Lung Nodules Based on CT Raw Data

The employ of medical images combined with deep neural networks to assist in clinical diagnosis, therapeutic effect, and prognosis prediction is nowadays a hotspot. However, all the existing methods are designed based on the reconstructed medical images rather than the lossless raw data. Considering that medical images are intended for …

cancer
  • 0 views
  • 19 Feb, 2024
  • 1 location
Lung Ultrasound in COVID-19 Patients

To assess the prognostic performance of an early global LUS score with respect to the mortality in ICU and duration of ventilation.

covid-19
PCR test
lung ultrasound
  • 0 views
  • 19 Feb, 2024
  • 1 location
Immunotherapy in Lung Cancer: Treatment After IO Cessation.

Immunotherapy is now a standard of care for first-line and eventually salvage therapy in patients with stage IV NSCLC and as adjuvant after RT-CT for stage III NSCLC. The aim of the study is determining the therapeutic landscape and the reason for immunotherapy cessation.

non-melanoma skin cancer
melanoma
carcinoma
carcinoma of the cervix
cancer
  • 0 views
  • 19 Feb, 2024
  • 5 locations
Thromboembolic Events in Severe COVID-19 Patients

The main objective of this study is to describe the incidence of thromboembolic events in a population of patients hospitalized in intensive care units in France for severe COVID-19. The secondary objective of this study is to describe the evolution of hemostasis parameters during the first two weeks of intensive …

covid-19
haemostasis
thromboembolism
acute respiratory syndrome (sars)
  • 0 views
  • 19 Feb, 2024
  • 1 location
Sequelae of Sars-CoV-2 Infections

By the end of 2019 a new coronavirus, named SARS-CoV-2, was discovered in patients with pneumonia in Wuhan, China. In the following weeks and months the virus spread globally, having a tremendous impact on global health and economy. To date, no vaccine or therapy is available. Severe courses of the …

cardiovascular system
coronavirus infection
pneumonia
acute respiratory syndrome (sars)
  • 0 views
  • 19 Feb, 2024
  • 1 location
Lung Function Exercise Capacity and Health-Related Quality of Life After Severe COVID-19

The medium and long-term impact in survivors of severe COVID-19 on lung function, exercise capacity and health-related quality of life remains to be determined.

respiratory distress
chest infection
anxiety
respiratory tract infection
respiratory infection
  • 0 views
  • 19 Feb, 2024
  • 5 locations
Evaluation of the Cell Detachment Ratio on pH-responsive Chitosan as a Prognostic Factor in Lung Cancer

The purpose of this project is to evaluate whether the cell detachment ratio on pH-responsive chitosan could be correlated with the overall survival in lung cancer patients. Through controllable cell-material interaction, this project has the intention to develop an alternative tool for both early diagnosis and accurate prognosis in cancer …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Impact of Sinus Surgery on Individuals With Cystic Fibrosis

This study will be a prospective, observational study of patients who undergo endoscopic sinus surgery for cystic fibrosis-related chronic rhinosinusitis (CRS). Individuals who do not undergo surgery but are treated medically for CRS will also be enrolled to serve as a control group. Outcomes analyzed will include pulmonary, quality of …

sinusitis
medical therapy
genetic testing
sweat test
cystic fibrosis
  • 0 views
  • 19 Feb, 2024
  • 1 location
MPA AUC Monitoring in Patients Receiving MMF for Diffuse Cutaneous or Pulmonary Involvement in Systemic Sclerosis

To define a target value of AUC MPA to improve the modified Rodnan score and / or respiratory impairment (DLCO or FVC) at one year in patients receiving MMF for the treatment of diffuse cutaneous or interstitial lung damage of systemic sclerosis.

immunosuppressive agents
chest x-ray
skin sclerosis
scleroderma
raynaud's phenomenon
  • 0 views
  • 19 Feb, 2024
  • 1 location